Dipti Babasaheb Patil

Dipti Babasaheb Patil

Active Director Director DIN 09380502
DIN 09380502 First appointment Oct 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Dipti Babasaheb Patil

Data last updated:

Dipti Babasaheb Patil is a Director at Shiv Cancer Center Private Limited (since 2021). The company operates in Healthcare.

DIN 09380502
Primary Designation Director
Industry Healthcare
First Appointment 28 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shiv Cancer Center Private Limited U85110KA2021PTC153739
Director28 Oct 20212021Active

Directorship timeline

Open interactive timeline →
Shiv Cancer Center Private Limited
Premium access

Shareholding and investment profile for Dipti Babasaheb Patil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipti Babasaheb Patil

Dipti Babasaheb Patil currently holds 1 directorship: Shiv Cancer Center Private Limited (Director, since 28 Oct 2021).

Dipti Babasaheb Patil was first appointed on 28 Oct 2021 as Director at Shiv Cancer Center Private Limited.

The current boards of Dipti Babasaheb Patil's companies include Arun Shrikant Kore (Shiv Cancer Center Private Limited), Dinshaw Marazban Hormuzdi (Shiv Cancer Center Private Limited), Leela Sharad Desai (Shiv Cancer Center Private Limited), Sharad Shankar Desai (Shiv Cancer Center Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available